CanBas

4575.T

Tags: JP Healthcare Biotechnology

CanBas Co., Ltd. Price (4575.T)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

17,814,296

(18.895)%

Market Cap of CanBas (4575.T)

Market cap:

As of , 4575.T has a market cap of . This makes 4575.T the 3722th most valuable company in the JP by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

CanBas Co., Ltd., a clinical stage biopharmaceutical company, develops therapeutics for cancer patients. It develops CBP501, a calmodulin-modulating peptide to treat various cancer; and CBS9106, a reversible exportin-1inhibitor that is in Phase I clinical trial for the treatment of solid tumors. The company has a collaboration alliance with Stemline Therapeutics, Inc. CanBas Co., Ltd. was incorporated in 2000 and is based in Numazu, Japan. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $429-1512
Market Cap 19.33B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Mr. Takumi Kawabe M.D., Ph.D.
IPO Date: September, 17, 2009
Country: JP
Currency: JPY
Headquaters: No Data
Employees: 11

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: